z-logo
open-access-imgOpen Access
Assessing the efficacy of novel oral anticoagulants after acute coronary syndrome
Author(s) -
Hamza Mohamed QabiL,
Ahmed Ramzy,
Mahmoud Shawky Abdelmoneum,
Khedr Ahmed Abd Elfattah
Publication year - 2018
Publication title -
cardiovascular system
Language(s) - English
Resource type - Journals
ISSN - 2052-4358
DOI - 10.7243/2052-4358-6-2
Subject(s) - acute coronary syndrome , medicine , intensive care medicine , cardiology , myocardial infarction
Background: After an acute coronary syndrome(ACS), patients continue to be at risk of major adverse cardiovascular events (MACE) despite the standard treatment. The risk of MACE may be secondary to thrombin,

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom